… of remissions and the impact of treatment on overall … long-term outcome of the FCR regimen
at a median follow up of 6 years. These results establish FCR as the most effective regimen …

… During the study period, there was no protocol-mandated salvage strategy for patients in …
outcomes of the individual salvage regimens were found to be similar on survival analysis. …

… original study, at a median of 12.8 years posttreatment, with a focus on identifying groups of
patients likely to achieve very long-term … -M had a highly favorable outcome following primary …

… On the basis of promising results that were reported in … rituximab to first-line chemotherapy
with fludarabine and … involved in the first and second amendments of the study protocol. The …

… the possibility that the use of such regimens may translate into an improved prognosis. …
to confirm the effect of the addition of rituximab to FC. Long-term follow-up of the effect of flow …

… (250 mg/m 2 per day) for the first 3 days or to intravenous … However, this regimen is associated
with substantial toxic effects, … A long-term follow-up of patients treated with fludarabine, …

… that RFC is a very effective regimen for relapsed/refractory patients. … Our study is the first to
use the oral route for fludarabine and … Our results cannot be compared with those of the Italian …

… , and impact of genomic risk factors has been limited. … these fludarabine and cyclophosphamide
combination regimens has … of the first chemoimmunotherapy protocols initiated in which …

… initial therapy but were randomized by violating the protocol. However, in all randomized
patients, the progression-free survival after initial … show a highly beneficial long-term effect of R …

… had received cyclophosphamide followed by rituximab. Among … bleed after the first 4 weekly
infusions of rituximab. Byrd et al … and rituximab are an active regimen in WM, although the …